BASOPHIL ACTIVATION TEST (BAT) IN »IN VITRO« DIAGNOSIS OFHYMENOPTERA VENOM HYPERSENSITIVITY
Abstract
BACKGROUND The basophil activation test relies on flow cytometric quantitation of the expression of themarkers on the surface of basophils, after stimulation with the amount of allergen thatcross-link IgE antibodies bound on their surface. In allergy diagnosis, the technique hasbeen applied in the investigation of IgE-mediated allergy caused by classical inhalant allergens,Hevea latex, food, drugs and hymenoptera venoms. The technique also proves valuablein the diagnosis of non-IgE-mediated reactions such as drug hypersensitivity and thedetection of autoantibodies in certain forms of chronic urticaria. To strengthen the probabilitythat the working diagnosis for hymenoptera venom hypersensitivity is correct, confirmatorytesting for skin test and IgE antibody is often performed. But sometimes clinical history and the results of confirmatory tests are contradictory. In such cases additionaltests are necessary, among which flow cytometric quantification of in vitro basophil activationis becoming a valuable tool during the last few years.Material and In Laboratory for Clinical Immunology and Molecular Genetic, Golnik, we performed BATmethods for 127 patients with history of anaphylactic reactions after Hymenoptera sting. CONCLUSIONS According to our findings BAT is a highly sensitive and specific technique and as an invitro provocation assay enables sensibilisation detection, prediction of side effects fromspecific immunotherapy and differentiates between clinically relevant and irrelevant epitops.This technique also gave us a new information on mechanisms and effects of venomimmunotherapyDownloads
Downloads
Published
Issue
Section
License
The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.